MYC and cancer: Indeed, cancer cells maintain their oncogenic signaling through acetylation of their epigenome, with the aberrant expression of MYC, BCL6 and BCL11A induced by acetylation of histone H3 lysine 27 (H3K27) in lymphoma as an example (Figure 1) (72).